Global respiratory syncytial virus treatment market to touch $2.3 bn by 2024

Singapore: The global Respiratory Syncytial Virus (RSV) treatment market will expand to unprecedented levels over the ne...

January 14, 2016 | Thursday | News
Bill & Melinda Gates Foundation supports Takeda with $38 m to eradicate polio

Japan's Takeda Pharmaceutical Company Limited has announced a partnership with the Bill & Melinda Gates Foundation t...

May 10, 2016 | Tuesday | News
Merck gets FDA nod for Bridion

Singapore: Merck (MSD) has recieved US Food and Drug Administration (FDA) approval for Bridion (sugammadex) Injection 10...

December 22, 2015 | Tuesday | Regulatory
BioDiem gets hepatitis vaccine tech from Canberra univ

Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement to lice...

June 29, 2012 | Friday | News
Infect mosquitoes with Wolbachia, stop diseases

Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected wi...

April 11, 2013 | Thursday | News
Takeda close to releasing Norovirus vaccine

Singapore: Japan's drug major Takeda Pharmaceutical has said that they are set to finish the early stage human studies o...

July 8, 2013 | Monday | News
China to set up a new vaccine tracking system

Singapore: According to a recent decision publicized by the Chinese government, wholesalers will no longer be allowed to...

April 27, 2016 | Wednesday | News
Yisheng BioPharma gets positive result in rabies vaccine trial

Singapore: Yisheng Biopharma, China based biopharmaceutical company, has recieved positive topline results from Phase I ...

January 4, 2016 | Monday | News
China's Hualan Bio gets WHO nod for influenza vaccine

Singapore: China based Hualan Bio has recieved world health organization (WHO) pre-qualification approval for influenza ...

June 18, 2015 | Thursday | News
Teikoku Pharma gets USFDA nod for non-alcohol docetaxel injection

Singapore: Japan's Teikoku Pharma has recieved USFDA approval for Docetaxel injection, a non-alcohol formula for the tre...

January 4, 2016 | Monday | News
German firm proceeds on ebola vaccine trial

Singapore: Germany based complex biologics development and manufacturing specialist, ProBioGen, has proceeded on the cli...

June 4, 2015 | Thursday | News
Merck's Ebola vaccine found promising in clinical trials

Singapore: In a recent interim study published in the Lancet medical journal, Merck's Ebola vaccine was found to be "hig...

August 3, 2015 | Monday | News
Teva recalls Adrucil injection for potential foriegn particle presence

Singapore: Teva Parenteral Medicines has recalled six lots of Adrucil (fluorouracil injection) due to the potential pres...

July 28, 2015 | Tuesday | Regulatory
Drug resistance keeps malaria threat alive in India

The current anti-malarial market in India is approximately $80 million (Rs 450 crore) with an annual growth rate of 17 p...

July 2, 2012 | Monday | Analysis
New vaccine against Hepatatis B developed by Cuba

Singapore: Researchers from Cuba have developed a new vaccine for treatment of chronic hepatitis B. The vaccine HeberNas...

August 17, 2015 | Monday | News
Malaria vaccine, Mosquirix, gets European nod

Singapore: GlaxoSmithKline has received a positive opinion for its Malaria vaccine candidate from the Committee for Medi...

July 24, 2015 | Friday | News
Novavax's Ebola vaccine shows promise in human trial

Singapore: US-based Novavax recently announced that its experimental candidate vaccine for Ebola showed promise in early...

July 22, 2015 | Wednesday | News
No more needles, no more pain!

Singapore: Vaccination will no longer be a painful process as researchers from Japan's Osaka University have developed a...

July 21, 2015 | Tuesday | News